A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight
Status:
COMPLETED
Trial end date:
2025-08-14
Target enrollment:
Participant gender:
Summary
The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to investigate weight management efficacy and safety with LY3841136 compared with placebo in adult participants with obesity or overweight. The study will last about 64 weeks and may include up to 17 visits.